Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

NCT00556530 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-07-22

No results posted yet for this study

Summary

22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.

Conditions

  • DiGeorge Syndrome
  • 22q11.2 Deletion Syndrome

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • University of Geneva, Switzerland

    collaborator OTHER
  • University of Toronto, Centre for Addiction and Mental Health (CAMH)

    collaborator UNKNOWN
  • Bambino Gesù Children's Hospital IRCCS

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • Cardiff University

    collaborator OTHER
  • Universidad del Desarrollo

    collaborator OTHER
  • Tel Aviv University

    collaborator OTHER
  • KU Leuven

    collaborator OTHER
  • Maastricht University

    collaborator OTHER
  • The Coriell Institute

    collaborator UNKNOWN
  • National Institute on Aging (NIA)

    collaborator NIH
  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Bernice E. Morrow, PhD · Albert Einstein College of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2029-06-30
Completion
2029-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00556530 on ClinicalTrials.gov